- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 12 residues within 4Å:- Chain A: R.2, C.23, D.24, S.25, F.26, L.103, K.106, S.107, S.110, E.112, G.113, K.413
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: P.3, C.4, G.46, R.47, R.48, E.50
Ligand excluded by PLIPEDO.9: 2 residues within 4Å:- Chain A: E.254, R.257
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain A: G.265, L.268, A.269, H.274, V.276, R.277, L.278, Y.304
Ligand excluded by PLIPEDO.11: 11 residues within 4Å:- Chain A: R.285, V.310, H.311, W.312, D.315, L.324, A.338, S.366, N.370, V.375, W.378
Ligand excluded by PLIPEDO.12: 9 residues within 4Å:- Chain A: G.344, S.345, K.346, F.347, E.349, Q.350, S.351, F.397, V.398
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: R.277, K.303, Y.304, V.305, H.306
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: L.165, V.172, S.173, L.174, K.224, L.225, Q.226
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain A: N.386, P.387, E.388
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain A: R.44, S.45, Y.487
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain A: P.245, V.394, N.396
- Ligands: Q68.17
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain A: I.130, R.131, T.132, W.393
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain A: L.69, Q.70, P.71, E.72, Q.73
Ligand excluded by PLIPEDO.22: 8 residues within 4Å:- Chain A: E.235, S.237, A.238, L.241, Y.244, D.283, Q.284
- Ligands: Q68.17
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain A: L.288, P.289, H.290, K.293
Ligand excluded by PLIPEDO.24: 5 residues within 4Å:- Chain A: F.75, L.372, Y.373, H.374, R.433
Ligand excluded by PLIP- 1 x Q68: ~{N}-[[1-[[(1~{S},2~{R},3~{R},4~{S},6~{S})-6-(hexylamino)-2,3,4-tris(oxidanyl)cyclohexyl]methyl]-1,2,3-triazol-4-yl]methyl]ethanamide(Covalent)
Q68.17: 22 residues within 4Å:- Chain A: C.126, D.127, F.128, W.179, N.234, E.235, Y.244, P.245, F.246, Q.284, H.311, Y.313, L.314, E.340, C.342, S.345, W.381, N.392, N.396, V.398
- Ligands: EDO.19, EDO.22
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:Y.313, A:E.340
- Hydrogen bonds: A:D.127, A:W.179, A:N.234, A:E.235, A:W.381, A:N.396
- Water bridges: A:S.345, A:S.345
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rowland, R.J. et al., Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents. Chemistry (2021)
- Release Date
- 2021-06-30
- Peptides
- Lysosomal acid glucosylceramidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BBB
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x Q68: ~{N}-[[1-[[(1~{S},2~{R},3~{R},4~{S},6~{S})-6-(hexylamino)-2,3,4-tris(oxidanyl)cyclohexyl]methyl]-1,2,3-triazol-4-yl]methyl]ethanamide(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rowland, R.J. et al., Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents. Chemistry (2021)
- Release Date
- 2021-06-30
- Peptides
- Lysosomal acid glucosylceramidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BBB